Clinical trials for IgG4-related disease
16 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPHASE1, PHASE2NCT07061938Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With IgG4-Related DiseaseAcepodia Biotech, Inc.
- RECRUITINGPhase 2NCT07025330A Study of Efgartigimod in Patients With IgG4-Related DiseaseStanford University · PI: Matthew C Baker, MD, MS
- RECRUITINGPhase 3NCT07190196A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related DiseaseSanofi
- RECRUITINGPhase 2NCT07148791Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related DiseaseChinese PLA General Hospital · PI: JIAN ZHU, M.D./Ph.D.
- RECRUITINGPHASE2, PHASE3NCT07068165A Randomized Controlled Study of the Efficacy and Safety of Lenalidomide in the Treatment of Active IgG4-related DiseasePeking Union Medical College Hospital
- RECRUITINGN/ANCT07104058A Study on the Effect of MRD Detected by FAPI PET / CT on the Recurrence of IgG4-RDLuo Yaping · PI: Yaping LUO, MD
- ACTIVE NOT RECRUITINGNCT06844864Adaptive and Trained Immunity in the Pathogenesis of IgG4-Related DiseaseIRCCS San Raffaele
- RECRUITINGEarly Phase 1NCT06497361Safety and Efficacy of PRG-2311 for Refractory Lupus Nephritis and IgG4-Related DiseaseTongji Hospital · PI: Lingli Dong
- RECRUITINGEarly Phase 1NCT06497387Safety and Efficacy of PRG-1801 for Refractory Lupus Nephritis and IgG4-Related DiseaseTongji Hospital · PI: Lingli Dong, MD
- RECRUITINGN/ANCT06663618Short-term Glucocorticoid Combined with MMF for IgG4-RDWen Zhang · PI: Wen Zhang, MD
- ACTIVE NOT RECRUITINGPhase 3NCT05662241A Phase 3 Study of Obexelimab in Patients With IgG4-Related DiseaseZenas BioPharma (USA), LLC
- RECRUITINGN/ANCT05789017Treatment Strategies for IgG4-RD Patients With Internal Organ InvolvementPeking Union Medical College Hospital · PI: Wen Zhang, MD
- RECRUITINGN/ANCT05789030Treatment Strategies for IgG4-RD Patients With Superficial Organ InvolvementPeking Union Medical College Hospital · PI: Wen Zhang, MD
- ACTIVE NOT RECRUITINGPhase 3NCT04540497A Study of Inebilizumab Efficacy and Safety in IgG4- Related DiseaseAmgen · PI: MD
- RECRUITINGNCT03023371National Registry of IgG4-RD in ChinaPeking Union Medical College Hospital
- RECRUITINGNCT01670695A Prospective Cohort Study of IgG4RD in ChinaPeking Union Medical College Hospital · PI: Wen Zhang, MD